Results 21 to 30 of about 86,262 (260)

Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database

open access: yesHaematologica, 2010
Background The risk of thromboembolic events in adults with primary immune thrombocytopenia has been little investigated despite findings of increased susceptibility in other thrombocytopenic autoimmune conditions.
Ameet Sarpatwari   +7 more
doaj   +1 more source

Primary immune thrombocytopenia in children

open access: yesPediatria Polska, 2021
Primary immune thrombocytopenia (ITP) is usually a benign and self-limiting disease in children. Due to the complex pathogenesis involving different immunological processes, its course may be unpredictable.
Agnieszka Książek, Tomasz Szczepański
doaj   +1 more source

Disseminated tuberculosis with severe immune thrombocytopenia

open access: yesRespiratory Medicine Case Reports, 2019
Immune thrombocytopenia is an autoimmune condition with increased platelet destruction. Immune thrombocytopenic purpura is an uncommon and rare manifestation of tuberculosis.
Malla Rama Krishna   +2 more
doaj   +1 more source

Role of thrombopoietin stimulating agents(Eltrombopag and Romiplostim) in immune thrombocytopenia secondary to SLE

open access: yesIatreia, 2021
Introduction: Immune thrombocytopenia is a frequent hematologic manifestation in systemic lupus erythematosus (SLE). Corticosteroids are the first line of treatment for moderate to severe thrombocytopenia in this disease, in conjunction with ...
Toro Vélez, Esteban   +2 more
doaj   +1 more source

Thrombocytopenia in pregnancy: is this immune thrombocytopenia or…? [PDF]

open access: yesHematology, 2012
Abstract Thrombocytopenia is a common finding in pregnancy. Establishing the diagnosis of immune thrombocytopenia (ITP) in a pregnant patient is similar to doing so in a nonpregnant patient, except that the evaluation must specifically rule out other disorders of pregnancy associated with low platelet counts that present different risks ...
openaire   +2 more sources

Fatigue in immune thrombocytopenia [PDF]

open access: yesBritish Journal of Haematology, 2015
SummaryFatigue is an important aspect of health‐related quality of life from the patient perspective and can have significant socio‐economic consequences. It is a common feature of chronic illnesses and a significant number of both adults and children with immune thrombocytopenia (ITP) suffer from fatigue.
Hill, QA, Newland, AC
openaire   +3 more sources

A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia

open access: yesHaematologica, 2016
Primary immune thrombocytopenia is an autoimmune disorder in which platelet destruction is a consequence of both B- and T-cell dysregulation. Flow cytometry was used to further characterize the B- and T-cell compartments in a cross-sectional cohort of 26
Shaun M. Flint   +8 more
doaj   +1 more source

Cross-reactivity between piperacillin–tazobactam and cefoperazone–sulbactam in drug-induced immune thrombocytopenia

open access: yesJournal of International Medical Research, 2023
Beta-lactam antibiotics commonly cause immune thrombocytopenia. Cross-reactivity in patients with drug-induced immune thrombocytopenia has rarely been reported. In this study, we describe the case of a 79-year-old man who developed thrombocytopenia after
Xiaoyan He   +5 more
doaj   +1 more source

Neonatal Immune Thrombocytopenia [PDF]

open access: yesMedical Journal Armed Forces India, 2004
Neonatal immune thrombocytopenia, a consequence of transplacental transfer of antiplatelet antibodies can result in serious bleeding with disastrous consequences in the otherwise healthy newborn.Over 2 years at a service hospital, 5 mothers with chronic autoimmune thrombocytopenia and one with maternal alloimmunisation delivered, which comprised the ...
Uma, Raju, Punita, Arora
openaire   +2 more sources

Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy

open access: yesFuture Science OA, 2020
Background: Immune-related adverse events are associated with efficacy of immune checkpoint inhibitors (ICIs). We hypothesize that immune-mediated thrombocytopenia could be a biomarker for response to ICIs.
Hussein A Assi   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy